The Invisible Threat: Why Micronanoplastics are a Systemic Immune Problem Across All Organ Systems
Published in Earth & Environment and Immunology
The Spark: Why This Review Now?
Over the last few years, research has confirmed that we ingest and inhale thousands of micronanoplastic (MNP) particles daily. Yet, the scientific community often operates in silos—studies on pulmonary effects are disconnected from those on reproductive failure or neurotoxicity.
This fragmentation led us to a crucial question: Is there a common mechanism linking these disparate adverse outcomes? We realized the scientific landscape required a comprehensive synthesis that connected these isolated "islands" of data, defining MNPs as a systemic, immunity-driven health problem.
The Challenge: Mapping the Immune Highway
The task was colossal. We had to synthesize evidence from human, animal, and in vitro models, covering eight major body systems (nervous, endocrine, respiratory, digestive, and others).
The greatest challenge was reconciling the vast differences in MNP data—particles varied in shape, size, material, and concentration across studies. We needed to identify a universal language of toxicity that could explain why such diverse particles lead to such consistently alarming pathologies.
Our Key Finding: Inflammation is the Common Thread
Our analysis revealed that MNPs are not passive, inert particles; they are active disruptors of cellular processes. The core mechanism of their harm is a cascading immune dysfunction, primarily manifesting through two pathways:
-
Oxidative Stress: MNPs induce excessive production of free radicals, damaging cells across all organs.
-
Immune Dysregulation: The particles trigger persistent, low-grade inflammation that can contribute to neuroinflammation, endocrine disruption, and other chronic illnesses.
In essence, we found that the immune system acts as the highway through which MNPs exert their systemic effects across the entire body.
The Research Agenda: What Happens Next?
Our review is not an endpoint; it is a roadmap. It’s a clear call to action for the scientific community. To effectively combat this global threat, standardization is essential. We urge researchers to:
-
Standardize Protocols: Adopt unified testing protocols and MNP characterization metrics to make results truly comparable globally.
-
Focus on Nanoplastics: Increase research on the smallest fraction—nanoplastics—as their capacity to cross biological barriers (like the blood-brain and placental barriers) presents the most significant threat.
-
Transition to Clinical Relevance: Develop clinical intervention and prevention strategies to protect human health from this pervasive environmental danger.
Follow the Topic
-
Discover Medicine
This is a fully open access, peer-reviewed journal that supports multidisciplinary research and policy developments across the fields of medical and clinical science.
Ask the Editor - Immunology, Pathogenesis, Inflammation and Innate Immunity
Got a question for the editor about the complement system in health and disease? Ask it here!
Continue reading announcementRelated Collections
With Collections, you can get published faster and increase your visibility.
Advances in Cardiovascular Diagnostics, Interventional Therapies, and Arrhythmia Management
Cardiovascular diseases remain a major global health challenge worldwide, continuing to be a leading cause of morbidity and mortality despite substantial advances in prevention and treatment. In recent years, progress in cardiovascular diagnostics, interventional techniques, and arrhythmia management has significantly improved patient care; however, important challenges persist, including timely diagnosis, individualized risk stratification, optimization of interventional strategies, and long-term outcome improvement. These unmet needs highlight the necessity for continued innovation and multidisciplinary research efforts in cardiovascular medicine.
This Collection aims to highlight recent advances in cardiovascular diagnostics, interventional therapies, and arrhythmia management, with a focus on clinically relevant and translational research. We welcome submissions addressing interventional cardiology procedures, catheter ablation techniques, three-dimensional electroanatomical mapping, mechanisms of cardiac arrhythmias, cardiovascular imaging, acute coronary syndromes, and hypertension. Contributions that enhance understanding of disease mechanisms, improve procedural outcomes, or inform clinical decision-making are particularly encouraged.
By bringing together high-quality experimental, clinical, and translational studies, this Collection seeks to advance scientific knowledge, support the development of improved therapeutic strategies, and foster global collaboration in the field of cardiovascular medicine.
Keywords:
Cardiology; Arrhythmia; Ablation; 3D mapping; Interventional cardiology; Hypertension; Acute coronary syndrome; Cardiovascular imaging; COVID-19
Publishing Model: Open Access
Deadline: Oct 12, 2026
Management of Breast Cancers in the Era of Artificial Intelligence
We are witnessing a full bloom of artificial intelligence (AI) in this day and age. The application of AI has been widely evaluated in different areas. One particular area is Oncology. Breast cancer is currently one of the commonest female cancers worldwide. Due to the intrinsic disease heterogeneity, tailored treatment with multi-disciplinary approach is the key to a successful treatment. AI has been considered as a potential tool to improve diagnostic and treatment outcomes of breast cancers.
This collection aims to compile good research articles evaluating the use of AI in the management of breast cancers. Potential topics include, but not limited to
1. AI in breast imaging
2. AI in breast pathology
3. AI in treatment decision making
4. AI in patient counselling
5. AI in breast cancer prognostication
Keywords:
1. Breast cancer
2. Breast oncology
3. Artificial Intelligence
4. Deep learning
5. Machine learning
Publishing Model: Open Access
Deadline: Dec 20, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in